AINDEX
Markets

Equillium, Inc. (EQ)

EQNASDAQ-CMBiotechnology: Pharmaceutical Preparations

$1.46

-0.0400 (-2.67%) today

Regular session, Nov 10, 2:25 PM ET

-2.67% 1D
Market cap
$114.41m
P/E
–
EPS, last 4 quarters
$-0.2000
Dividend yield
–
Day range
$1.45 to $1.52
52-week range
$0.7562 to $3.54
Average volume
561.5k
Previous close
$1.50

Analysts

5 covering

Buy5 buy, 0 hold, 0 sell

Targets a year out average $11.00, +653.4% from here

$6.00now $1.46$20.00

Earnings

next estimate $-0.0500

Next report Nov 12, 2026

Sep 2025

+57.1%

Dec 2025

+42.9%

Mar 2026

-50.0%

Jun 2026

+20.0%

estimate reported, and the surprise

Financials

QuarterSep 2025Dec 2025Mar 2026Jun 2026
Revenue––––
Gross profit––––
Operating income-$4.57m-$3.96m-$5.61m-$5.16m
Net income-$4.23m-$3.77m-$5.31m-$4.69m

News

8 latest

The company

Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat serious autoimmune and inflammatory disorders.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.